ATCC (American Type Culture Collection)

ATCC offers a wide range of cell products including primary cells, cell models, and assay-ready cells for various research applications.

ATCC provides a comprehensive collection of microbial strains for research and quality control purposes.

ATCC offers various services including cell authentication, microbial identification, and custom solutions to support scientific research.

ATCC provides solutions tailored for federal agencies, supporting their research and development needs.

ATCC supports each stage of the diagnostic development process by providing authenticated live strains, quantitative molecular standards, and next-generation sequencing standards.

ATCC supports bioproduction research and development projects by providing resources for industrial bioprocessing and cell-based applications, including cell lines for enhanced virus production and microbial bioproduction.

ATCC offers secure biomaterial deposit services, including authentication, storage, maintenance, and global distribution of biological samples, ensuring the security of biomaterial storage with expert staff and temperature-controlled facilities.

A solution for predictive drug development and toxicity testing.

Cells that go from frozen to data in 1 day, facilitating quick assay setup. These cells are versatile and can be used in various research applications such as immune system disorder research, immunology research, and toxicology research.

Precisely quantitated RNA preparations for enhanced assay compatibility.

Microbial controls in a single-use format for streamlined microbial QC testing.

ATCC provides a wide variety of next-generation 2-D and 3-D patient-derived in vitro cancer models from numerous tissues, essential for studying cancer and facilitating translational research.

ATCC offers a variety of patient-derived organoids from healthy and cancerous tissues, supporting advanced research in oncology.

Developed to simplify organoid culture, these kits are tailored for each of ATCC’s organoid subtypes.

Facilitate therapeutic development with luciferase reporter cells that express immune checkpoint molecules.

Accelerate CAR-T therapy development with luciferase reporter solid and liquid tumor cell lines that express surface tumor antigens.

Luciferase reporters containing the response element of immunologically important transcription factors into the THP-1 cell line.

ATCC primary immune cells support complex physiologically relevant research projects, including cancer immunology studies.

Includes immune cells, CD34+ and CD14+ progenitor cells, primary mononuclear cells, lymphocytes, and leukocytes.

A wide selection of hybridomas that secrete antibodies targeting specific cellular epitopes.

Pre-plated, cryopreserved 3-D tumor spheroids for high-throughput screening.

ATCC Primary Cell Solutions consist of quality cells, reagents matched and optimized to work with each cell type, and trustworthy protocols.

Isogenic cell lines with mutations in key oncogenes created using genome editing tools such as CRISPR/Cas9.

Combine the in vivo nature of primary cells with the traditional cell line's ability to survive continuously in vitro.

Designed to enable the real-time monitoring of the changing status of cells from epithelial to mesenchymal.

Valuable tools for drug discovery and development as well as studies on tissue repair and disease pathogenesis.

Authenticated tumor-derived cell lines matched to normal healthy cells from the same donor.

Extensive selection of cancer panels grouped by tissue type, genetic mutation, or molecular signature.

Provide a robust and highly sensitive means to measure biological processes and assess drug efficacy in live animal models.

Provide a measurable and distinguishable phenotype for the analysis of tumor biology.

Derived from hTERT-immortalized mesenchymal stem cells representing prostate, colorectal, and lung cells.

Extracted from patient samples or cell lines that contain biomarkers quantified by validated methods.

MicroQuant™ is ATCC's new product line of precisely quantitated microbial reference materials used to streamline microbial quality control testing in pharmaceutical manufacturing. Leveraging an innovative cryopreservation technology, MicroQuant™ products come in the form of stable, rapidly rehydrating pellets that deliver consistent quantitation and accurate, reproducible results—addressing the key challenges faced by microbial testing laboratories.

HepatoXcell™ Pro are Primary Human Hepatocytes, 7 day Plateable are derived from normal, healthy, human liver tissues.

HepatoXcell™ Plus are Primary Human Hepatocytes, 3 day Plateable are derived from normal, healthy, human liver tissues.

HepatoXcell™ Eco Primary Human Hepatocytes Suspension Cells are derived from normal, healthy, human liver tissues.

Maximize the viability and functionality of your HepatoXcell™ hepatocytes with specially formulated media.

Brown preadipocytes were isolated from deep perirenal adipose tissue and have applications in toxicity studies and the study of obesity.

White preadipocytes were isolated from subcutaneous abdominal adipose tissue and have applications in toxicity studies and the study of obesity.

Senior Vice President, ATCC Federal Solutions

Senior Director of Business Development, ATCC Federal Solutions (AFS)

Director, Government Programs, ATCC Federal Solutions (AFS)

Director, Contracts, ATCC Federal Solutions (AFS)